Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

NCT07267949 is registered in ClinicalTrials.gov with Acesion Pharma as lead sponsor.

NCT NCT07267949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Lead sponsor
Acesion Pharma
Phase
Phase 2
Overall status
Recruiting
Start date
October 22, 2025
Completion date
June 30, 2027
Enrollment
200 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)